InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

WORK Medical Technology Group LTD

WOK Clue Score40
China Fiscal year ends September CIK 0001929783
$1.53 +0.66% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.53 +1,586.88% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 23 Aug 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2022Revenue19.7Net income0.9EPS, diluted0.07Fiscal year 2023Revenue13.6 −31.2%Net income0.1 −87.1%EPS, diluted0.01Fiscal year 2024Revenue11.5 −15.2%Net income−3.5 −3,217.3%EPS, diluted−0.27Fiscal year 2025Revenue9.8 −14.4%Net income−1.1EPS, diluted−0.04
FY2022FY2023FY2024FY2025
Revenue 19.7 13.6 11.5 9.8
Growth −31.2% −15.2% −14.4%
Net income 0.9 0.1 −3.5 −1.1
Growth −87.1% −3,217.3%
EPS, diluted 0.07 0.01 −0.27 −0.04

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginNet margin
Fiscal year 2022Gross margin22.4%Net margin4.4%Free cash flow margin−21.7%Fiscal year 2023Gross margin30.5%Net margin0.8%Free cash flow margin12.9%Fiscal year 2024Gross margin24.9%Net margin−30.4%Free cash flow margin−99.5%Fiscal year 2025Gross margin23.8%Net margin−10.9%Free cash flow margin49.9%
FY2022FY2023FY2024FY2025
Gross margin 22.4% 30.5% 24.9% 23.8%
Net margin 4.4% 0.8% −30.4% −10.9%
Free cash flow margin −21.7% 12.9% −99.5% 49.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−2.3Capital expenditure−2.0Free cash flow−4.3Fiscal year 2023Operating cash flow2.2Capital expenditure−0.5Free cash flow1.8Fiscal year 2024Operating cash flow−2.2Capital expenditure−9.2Free cash flow−11.5 −752.8%Fiscal year 2025Operating cash flow6.2Capital expenditure−1.3Free cash flow4.9
FY2022FY2023FY2024FY2025
Operating cash flow −2.3 2.2 −2.2 6.2
Capital expenditure −2.0 −0.5 −9.2 −1.3
Free cash flow −4.3 1.8 −11.5 4.9
Growth −752.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash0.7Shareholders’ equity11.2Fiscal year 2023Cash1.6Shareholders’ equity9.9Fiscal year 2024Cash6.6Shareholders’ equity13.2Fiscal year 2025Cash4.1Shareholders’ equity18.3
FY2022FY2023FY2024FY2025
Cash 0.7 1.6 6.6 4.1
Shareholders’ equity 11.2 9.9 13.2 18.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 30 Sep 2022 FY2023 30 Sep 2023 FY2024 30 Sep 2024 FY2025† 30 Sep 2025
Revenue and profit
19.7 13.6 11.5 9.8
Growth −31.2% −15.2% −14.4%
4.4 4.1 2.9 2.3
Growth −6.2% −30.8% −18.3%
0.2 0.3 0.3 0.4
2.6 1.9 4.6 2.3
1.1 0.1 −3.7 −1.1
0.2 0.0 −0.1 0.1
0.9 0.1 −3.5 −1.1
Growth −87.1% −3,217.3%
Per share
0.07 0.01 −0.27 −0.04
0.07 0.01 −0.27 −0.04
Growth −85.7% −2,800.0%
12.5 12.5 12.7 29.0
12.5 12.5 12.7 29.0
Growth +0.0% +1.6% +128.1%

† The diluted share count jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 4 years on file.